Psychopharmacology for Children and Adolescents . WHAT PSYCHOLOGISTS AND COUNSELORS WHO WORK WITH KIDS SHOULD KNOW. FDA Approval. Resource for Pediatric FDA medication approval. www.fda.gov/cder/drugsatfda. Trends .
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
WHAT PSYCHOLOGISTS AND COUNSELORS WHO WORK WITH KIDS SHOULD KNOW.
Augmentation for anxiety
Goodwin F, Jamison K. Manic Depression. New York: Oxford University Press; 1990.
FDA approved ABILIFY® (aripiprazole) for the acute treatment of manic and mixed episodes, maintenance treatment of manic or mixed episodes, and as add-on treatment to lithium or valproate, associated with Bipolar I Disorder, with or without psychotic features, and schizophrenia in pediatric patients (10 to 17 years old).
No blood tests
Once a day dosing
FDA approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.
Some reports of mania induction
Diabetes riskTreatment: Risperidone (Risperdal)